Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Transcatheter Arterial Embolization Using Nexsphere-F for Chronic Shoulder Pain Refractory to Conservative Treatment

Evaluation of the efficacy and safety of transcatheter arterial embolization using 'Nexsphere-F' for pain relief in patients with adhesive capsulitis of the shoulder joint that does not respond to conservative treatment. This study aims to investigate the efficacy and safety of transcatheter arterial embolization using embolic agents in patients with adhesive capsulitis of the shoulder joint. This is a single-center, prospective, open-label, randomized clinical trial.

Participants needed: 44
Trial details
Age: 19-85Biological sex: AllType: InterventionalSponsor: Chung-Ang University Hosptial, Chung-Ang University College of MedicineUpdated: May 19, 2026Locations: 1
Eligibility criteria

Patients who have voluntarily signed a written informed consent form after recei... [+4]

Patients with a history of surgery on the shoulder joint targeted for the clinic... [+4]

Status: Not yet recruiting

12-mm Partial Covered Versus Bare Self-Expandable Metallic Stents for Malignant Distal Biliary Obstruction

Metallic stents are commonly used for biliary drainage in patients with unresectable malignant distal biliary obstruction. However, it is unclear whether a 12-mm partially covered self-expandable metallic stent or a 12-mm bare self-expandable metallic stent provides better effectiveness and safety. This prospective, randomized clinical trial will compare these two stent types in adult patients who have already undergone percutaneous transhepatic biliary drainage (PTBD) and are scheduled for metallic stent placement through the existing PTBD tract. A total of 60 participants will be enrolled. After stent placement, participants will be followed for 12 months, with assessments at 3, 6, and 12 months. The study will evaluate recurrent biliary obstruction, stent patency duration, reintervention, overall survival, and procedure-related complications. The results are expected to provide evidence for selecting the most appropriate 12-mm metallic stent for patients with unresectable malignant distal biliary obstruction.

Participants needed: 60
Trial details
Age: 19+Biological sex: AllType: InterventionalSponsor: Chung-Ang University Hosptial, Chung-Ang University College of MedicineUpdated: May 6, 2026
Eligibility criteria

Patients who voluntarily provide written informed consent after receiving suffic... [+3]

Patients with a previous history of biliary metallic stent placement [+3]